3-(4-bromophenyl)-1-(2-hydroxyphenyl)imidazo[2,1-b]quinazolin-5-one

Names

[ CAS No. ]:
107605-01-6

[ Name ]:
3-(4-bromophenyl)-1-(2-hydroxyphenyl)imidazo[2,1-b]quinazolin-5-one

Chemical & Physical Properties

[ Density]:
1.55g/cm3

[ Boiling Point ]:
594.5ºC at 760 mmHg

[ Molecular Formula ]:
C22H14BrN3O2

[ Molecular Weight ]:
432.26900

[ Flash Point ]:
313.3ºC

[ Exact Mass ]:
431.02700

[ PSA ]:
59.53000

[ LogP ]:
4.77350

[ Vapour Pressure ]:
9.94E-15mmHg at 25°C

[ Index of Refraction ]:
1.735

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NJ5902605
CHEMICAL NAME :
Imidazo(2,1-b)quinazolin-5(1H)-one, 3-(4-bromophenyl)-1-(2-hydroxyphenyl)-
CAS REGISTRY NUMBER :
107605-01-6
LAST UPDATED :
199212
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C22-H14-Br-N3-O2
MOLECULAR WEIGHT :
432.30

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
INDRBA Indian Drugs. (Indian Drugs Manufacturers' Assoc., 102B, Poonam Chambers, Dr. A. B. Rd., Worli, Bombay 400 018, India) V.1- 1963- Volume(issue)/page/year: 24,16,1986

Related Compounds

  • 4-(1-aminoethyl)-N-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)benzene-1-sulfonamide
  • 4-hydrazinyl-N-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)benzene-1-sulfonamide
  • 5-Chloro-I(2)-cyclopropyl-2-thiophenepropanamide
  • 1-[2-Chloro-1-(2-thienyl)ethyl]piperidine
  • 4-amino-N-(2-methyl-2H-1,2,3,4-tetrazol-5-yl)benzene-1-sulfonamide
  • 2,4-Dichloro-1-(2-isocyanatopropan-2-yl)benzene
  • 2-Methyl-4-[2-(methylthio)ethyl]-5(4H)-oxazolone
  • 1-Amino-1-(3-bromophenyl)propan-2-OL
  • 2-[1-(2,4-Dichlorophenyl)cyclopropyl]ethan-1-amine
  • 2-[1-(3,4-Dichlorophenyl)cyclopropyl]ethan-1-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.